Literature DB >> 25264295

Current symptomatology in multiple sclerosis and neuromyelitis optica.

M Muto1, M Mori, Y Sato, A Uzawa, S Masuda, T Uchida, S Kuwabara.   

Abstract

BACKGROUND AND OBJECTIVES: Several symptoms and signs are characteristic of multiple sclerosis (MS) such as Lhermitte's sign, Uhthoff's phenomenon and painful tonic seizure. Neuromyelitis optica (NMO) is another inflammatory disease of the central nervous system, and most of the opticospinal form of MS is thought to be NMO. This study aimed to investigate the frequencies of symptoms and signs, previously regarded as characteristic of MS, in NMO and MS patients.
METHODS: Consecutive Japanese NMO-plus patients [NMO (n = 30) or partial NMO (n = 18)] and MS patients (n = 128) seen at Chiba University Hospital between 2011 and 2012 were investigated for the frequencies of symptoms and signs characteristic of MS. Logistic regression analyses were used to identify factors that distinguished NMO-plus from MS.
RESULTS: Univariate analyses revealed that tonic seizures, Lhermitte's sign, persistent pain, fatigue and girdle sensation were more frequent in NMO-plus patients than in MS patients. Multivariate logistic regression analysis showed that paroxysmal itching, Uhthoff's phenomenon, Lhermitte's sign and girdle sensation were more characteristic of NMO-plus than of MS.
CONCLUSIONS: Several classical MS symptoms and signs are more frequent in NMO patients than MS patients, which may be caused by the differences in the severity of inflammation, and localization and extensiveness of demyelinated lesions.
© 2014 EAN.

Entities:  

Keywords:  multiple sclerosis; neuromyelitis optica; paroxysmal symptoms; symptomatology

Mesh:

Year:  2014        PMID: 25264295     DOI: 10.1111/ene.12566

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Hypoxemia, Sleep Disturbances, and Depression Correlated with Fatigue in Neuromyelitis Optica Spectrum Disorder.

Authors:  Jing Pan; Peng Zhao; Hao Cai; Lei Su; Kristofer Wood; Fu-Dong Shi; Ying Fu
Journal:  CNS Neurosci Ther       Date:  2015-06-01       Impact factor: 5.243

Review 2.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

Review 3.  Fatigue as a symptom or comorbidity of neurological diseases.

Authors:  Iris-Katharina Penner; Friedemann Paul
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

4.  Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement.

Authors:  Melis Şen; Ece Akbayır; Özlem Mercan; Erdil Arsoy; Mehmet Gencer; Vuslat Yılmaz; Cem İsmail Küçükali; Erdem Tüzün; Recai Türkoğlu
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

Review 5.  Uhthoff`s phenomenon 125 years later - what do we know today?

Authors:  J A Opara; W Brola; A A Wylegala; E Wylegala
Journal:  J Med Life       Date:  2016 Jan-Mar

6.  Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Hiroki Masuda; Masahiro Mori; Akiyuki Uzawa; Tomohiko Uchida; Ryohei Ohtani; Satoshi Kuwabara
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

7.  Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study.

Authors:  José E Meca-Lallana; Rocío Gómez-Ballesteros; Francisco Pérez-Miralles; Lucía Forero; María Sepúlveda; Carmen Calles; María L Martínez-Ginés; Inés González-Suárez; Sabas Boyero; Lucía Romero-Pinel; Ángel P Sempere; Virginia Meca-Lallana; Luis Querol; Lucienne Costa-Frossard; Daniel Prefasi; Jorge Maurino
Journal:  Neurol Ther       Date:  2022-05-06

8.  A Case Study of Intractable Vomiting with Final Diagnosis of Neuromyelitis Optica.

Authors:  Rachel Bramson; Angela Hairrell
Journal:  Case Rep Pediatr       Date:  2015-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.